Back to all bills
S 3076119th CongressIn Committee
Nitazene Control Act
Introduced: Oct 30, 2025
Sponsor: Sen. McCormick, David [R-PA] (R-Pennsylvania)
Standard Summary
Comprehensive overview in 1-2 paragraphs
The Nitazene Control Act permanently schedules 2-benzylbenzimidazole opioids (nitazenes) as Schedule I controlled substances.
Key Points
- 1Class-wide permanent scheduling of nitazenes in Schedule I
- 2Includes comprehensive chemical structure definitions
- 3Removes temporary scheduling status for existing nitazenes
- 4Maintains research pathways under HALT Fentanyl Act
- 5Prohibits new research without proper registration
- 6Addresses synthetic opioids more potent than fentanyl
Impact Areas
Drug enforcement and schedulingSynthetic opioid manufacturersPublic health and overdose preventionResearch institutionsCriminal justice systemSubstance abuse treatment
Generated by kwaipilot/kat-coder-pro:free on Nov 19, 2025